Vistin Pharma ASA reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was NOK 110.72 million compared to NOK 110.93 million a year ago. Net income was NOK 18.03 million compared to NOK 16.93 million a year ago. Basic earnings per share from continuing operations was NOK 0.41 compared to NOK 0.38 a year ago.
For the full year, sales was NOK 438.33 million compared to NOK 304.85 million a year ago. Net income was NOK 45.64 million compared to net loss of NOK 4.69 million a year ago. Basic earnings per share from continuing operations was NOK 1.03 compared to basic loss per share from continuing operations of NOK 0.11 a year ago.